Jiuzi Holdings, Inc. Announces Up to $30 Million Private Placement for Cryptocurrency Acquisition
HANGZHOU, China, Oct. 2, 2025 /PRNewswire/ -- Jiuzi Holdings, Inc. (NASDAQ: JZXN; the…
XOMA Royalty Extends Tender Offer to Acquire LAVA Therapeutics N.V.
EMERYVILLE, Calif. and UTRECHT, The Netherlands and PHILADELPHIA, Oct. 02, 2025 (GLOBE…
Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
October 01, 2025 17:20 ET | Source: ZENTALIS PHARMACEUTICALS SAN DIEGO, Oct.…
Scilex Holding Company Announces Signing of a Securities Purchase Agreement with an Institutional Investor to Exchange $200 Million of Common Stock of Semnur Pharmaceuticals, Inc. Held By Scilex Holding Company for $200 Million in Bitcoin
PALO ALTO, Calif., Sept. 23, 2025 (GLOBE NEWSWIRE) -- Scilex Holding Company…
Five Point Announces Expiration and Results of Cash Tender Offer for Any and All Outstanding 10.500% Initial Rate Senior Notes Due 2028
IRVINE, Calif.--(BUSINESS WIRE)--Five Point Holdings, LLC (“Five Point”) (NYSE: FPH) announced today…
Best Kratom Brand: Happy Go Leafy, Ranked #1 Kratom Vendor by Plastic Surgery Key
Miami, Florida, Sept. 15, 2025 (GLOBE NEWSWIRE) -- Plastic Surgery Key, an…
Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
September 12, 2025 16:30 ET | Source: Fulcrum Therapeutics, Inc. CAMBRIDGE, Mass.,…
TBO TO ACQUIRE CLASSIC VACATIONS FROM THE NAJAFI COMPANIES TO EXPAND ITS GLOBAL REACH INTO NORTH AMERICA
TBO's purchase of the leading U.S. luxury travel wholesaler elevates its premium…
Aja Health and Wellness Inc. Announces Agreement for the Purchase of Assets of Canadian Travel and Doctors Clinics Inc., Announces Share Subscription Agreement with GEM Global Yield LLC SCS, and Provides Update on Delay in Filing Financial Statements
August 29, 2025 19:34 ET | Source: Aja Health and Wellness Inc.…
Calidi Biotherapeutics Announces Closing of $6.9 Million Underwritten Public Offering and Full Exercise of Underwriters Over-Allotment Option
SAN DIEGO, Aug. 21, 2025 (GLOBE NEWSWIRE) -- Calidi Biotherapeutics, Inc. (NYSE…